Medical Condition News

RSS

Leptin hormone also regulates airway diameter

A new study led by Columbia University Medical Center (CUMC) researchers has found that leptin, a hormone that plays a key role in energy metabolism, fertility, and bone mass, also regulates airway diameter.

9 Jan 2013

Moms more likely to use TV to entertain and soothe fussy infants

Moms, especially those who are obese, are more likely to use TV to entertain and soothe infants who are more fussy and active, according to researchers at the University of North Carolina at Chapel Hill. The finding adds to the growing body of knowledge that may help explain the escalating rate of obesity and inactivity in U.S. children, and has led to behavioral and educational strategies that may help mothers combat these effects.

9 Jan 2013

RPB honors Mass. Eye and Ear ophthalmologist with Senior Scientific Investigator Award

Reza Dana, M.D., M.P.H., M.Sc. of Mass. Eye and Ear/Harvard Medical School, was awarded the Research to Prevent Blindness (RPB) Senior Scientific Investigator Award in the amount of $150,000 to support research into the causes, treatment and prevention of blinding diseases.

9 Jan 2013

Glycan released by parasites might help treat metabolic disorders associated with obesity

On the list of undesirable medical conditions, a parasitic worm infection surely ranks fairly high. Although modern pharmaceuticals have made them less of a threat in some areas, these organisms are still a major cause of disease and disability throughout much of the developing world.

9 Jan 2013

Metabolic stress can increase onset of atrial fibrillation

Researchers have found new evidence that metabolic stress can increase the onset of atrial arrhythmias, such as atrial fibrillation (AF), a common heart condition that causes an irregular and often abnormally fast heart rate.

9 Jan 2013

VolitionRx to commence large internal clinical study for Nucleosomics diagnostic products

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that it will commence a large internal clinical study for its Nucleosomics diagnostic products this month.

9 Jan 2013

Moffitt Cancer Center initiates PV-10 Phase 1 study in melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports that the Moffitt Cancer Center has initiated a Phase 1 study to investigate potential immune biomarkers in both tumor tissue and peripheral blood after intralesional PV-10 injection of melanoma tumors.

9 Jan 2013

Study shows troubling racial disparities in completion of alcohol and drug abuse programs

Roughly half of all black and Hispanic patients who enter publicly funded alcohol treatment programs do not complete treatment, compared to 62 percent of white patients, according to a new study from a team of researchers including the Perelman School of Medicine at the University of Pennsylvania.

9 Jan 2013

High court turns away challenge to Obama administration stem cell policy

Meanwhile, the Supreme Court heard arguments in a case involving Medicaid and malpractice awards. In addition, the justices rejected an appeal from Social Security recipients who don't want Medicare benefits.

9 Jan 2013

Kingston University professor receives prestigious prize for work on drug metabolism

The Dean of the Faculty of Science, Engineering and Computing at London's Kingston University has received a prestigious prize recognising her lifetime's work on drug metabolism.

9 Jan 2013

Abnormal fixation may contribute to deficits in face perception in AMD patients

Abnormalities of eye movement and fixation may contribute to difficulty in perceiving and recognizing faces among older adults with age-related macular degeneration (AMD), suggests a study "Abnormal Fixation in Individuals with AMD when Viewing an Image of a Face" appearing in the January issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

9 Jan 2013

Overall cancer death rates continue to decline in the U.S.: Report

The Annual Report to the Nation on the Status of Cancer, 1975-2009, shows that overall cancer death rates continued to decline in the United States among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including lung, colon and rectum, female breast, and prostate.

9 Jan 2013

Body's sodium levels fluctuate rhythmically with 7-day and monthly cycles

Clinical pharmacologist Jens Titze, M.D., knew he had a one-of-a-kind scientific opportunity: the Russians were going to simulate a flight to Mars, and he was invited to study the participating cosmonauts.

9 Jan 2013

Researchers develop new materials to support stem cell growth

Stem cell manufacturing for drug screening and treatments for diseases such as Huntington's and Parkinson's could be boosted by a new method of generating stem cells, a study suggests.

9 Jan 2013

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

Cell Therapeutics, Inc. (CTI) today announced that the Company has initiated clinical trial sites and began enrolling patients in a Phase 3 clinical trial, known as PERSIST-1 or PAC325, for pacritinib, CTI's investigational JAK2 inhibitor, which is being evaluated for the treatment of patients with myelofibrosis.

9 Jan 2013

New scoring system can help clinicians better identify non-ICU patients at risk for GI bleeding

Critically ill patients in hospital intensive care units (ICUs) are routinely prescribed acid-suppressive medications to reduce their risk of developing stress ulcers and gastrointestinal bleeding, both of which can result from being in a stressful environment and from being intubated. Over the years, this routine practice has often been extended to patients outside the ICU, despite a lack of evidence that this population is at significant risk of these complications.

9 Jan 2013

Wockhardt receives final FDA approval for Lamotrigine to treat epilepsy

Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg, 200mg and 300mg extended release tablets of Lamotrigine, which is used in treatment of epilepsy.

9 Jan 2013

Brown University receives Irene Diamond Fund gift to launch major initiative on healthy aging

Brown University's Program in Public Health has received a gift from the Irene Diamond Fund to launch a major initiative on healthy aging.

9 Jan 2013

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

Boehringer Ingelheim and Eli Lilly and Company today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor being studied for treatment of patients with Type 2 Diabetes (T2D).

9 Jan 2013

Combination of pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer

A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine.

9 Jan 2013

Medical Condition News

Leptin hormone also regulates airway diameter

Moms more likely to use TV to entertain and soothe fussy infants

RPB honors Mass. Eye and Ear ophthalmologist with Senior Scientific Investigator Award

Glycan released by parasites might help treat metabolic disorders associated with obesity

Metabolic stress can increase onset of atrial fibrillation

VolitionRx to commence large internal clinical study for Nucleosomics diagnostic products

Moffitt Cancer Center initiates PV-10 Phase 1 study in melanoma

Study shows troubling racial disparities in completion of alcohol and drug abuse programs

High court turns away challenge to Obama administration stem cell policy

Kingston University professor receives prestigious prize for work on drug metabolism

Abnormal fixation may contribute to deficits in face perception in AMD patients

Overall cancer death rates continue to decline in the U.S.: Report

Body's sodium levels fluctuate rhythmically with 7-day and monthly cycles

Researchers develop new materials to support stem cell growth

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

New scoring system can help clinicians better identify non-ICU patients at risk for GI bleeding

Wockhardt receives final FDA approval for Lamotrigine to treat epilepsy

Brown University receives Irene Diamond Fund gift to launch major initiative on healthy aging

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

Combination of pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News